Latest Financial Health News

Health and Plant Protein Group Ltd (HPP) ended FY25 Q4 with a strong cash position following a significant IRS payment, while signaling plans for shareholder returns and confidential corporate opportunities.

Clean TeQ Water Limited reported solid progress across multiple key projects and improved cash receipts in its Q4 FY25 update, underscoring its growing foothold in advanced water treatment and resource recovery.

Weebit Nano reports solid progress in Q4 FY25 with key technology milestones and its first product design license, backed by a strong cash position.

Mustera Property Group advances its North Fremantle McCabe Street project with a planned sales launch in Q3 2025, while settling two Forbes Residences units for $4.6 million, underpinning positive cash flow and refinancing benefits.

Stonehorse Energy Limited reported steady Q2 2025 results, driven by strong Canadian production despite lower commodity prices and operational setbacks in the US. The company also announced a strategic board appointment as it pursues growth opportunities.

Pure Hydrogen reports a second consecutive quarter of positive cash flow, expands its international hydrogen vehicle footprint, and secures a 15-year gas project permit in Queensland.

Savannah Goldfields reported a $4.06 million cash outflow in Q2 2025 but is advancing plans to restart gold production and secure additional funding.

Starpharma reports a 165% rise in FY25 customer receipts, advances its clinical-stage DEP® assets, and secures new distribution deals in Asia and Saudi Arabia.

FirstWave Cloud Technology reports a slight revenue decline in Q4 FY25, offsets challenges with strategic restructuring and a new AWS marketplace partnership.

Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.

Group 6 Metals Limited has reported record quarterly tungsten production and sales, completed a major recapitalisation reducing debt, and is transitioning from open cut to underground mining at its Dolphin Tungsten Mine.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.